Company Profile

Nanocopoeia Inc
Profile last edited on: 8/16/11      CAGE: 4B2Q7      UEI:

Business Identifier: Nanoscale drug material formulations, Nano-encapsulated drug formulations, Advanced performance drug eluting coatings for medical devices
Year Founded
2001
First Award
2005
Latest Award
2008
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1246 West University Avenue Suite 463
St Paul, MN 55104
   (651) 209-1184
   N/A
   www.nanocopoeia.com
Location: Single
Congr. District: 04
County: Ramsey

Public Profile

Nanocopoeia Inc. has developed a novel electrospray system for the production of nanoparticles. The business of Nanocopoeia is the therapeutic use of those nanoparticles in medical applications. Our patented ElectroNanospray™ (ENS) process is currently being used to produce complex coatings for medical devices and to nanoformulate drugs for enhanced bioavailabilit

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 2 NSF $565,032
Project Title: ElectroNanospray Process for Nanoformulating Drugs
2006 2 NSF $599,364
Project Title: Nanocomposite Coating on Coronary Stents
2005 1 NIH $261,033
Project Title: Electrospraying Nanoparticle Coatings on Stents

Key People / Management

  Karen Arnold -- Co-Founder, CEO, Business Development

  Robert A Hoerr -- President and Co-Founder

  Jane Nichols -- Director of Business Development

  David Y H Pui -- Scientific Board of Advisors

  Pat Ryan -- advanced technology

  Alex Xue -- VP Marketing

Company News

There are no news available.